Return On Assets of Rein Therapeutics, Inc. from 31 Mar 2018 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Rein Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 31 Mar 2018 to 30 Sep 2025.
  • Rein Therapeutics, Inc. Return On Assets for the quarter ending 30 Sep 2025 was -102%, a 265% decline year-over-year.
  • Rein Therapeutics, Inc. annual Return On Assets for 2024 was -67%, a 60% decline from 2023.
  • Rein Therapeutics, Inc. annual Return On Assets for 2023 was -42%, a 53% increase from 2022.
  • Rein Therapeutics, Inc. annual Return On Assets for 2022 was -89%, a 94% decline from 2021.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Rein Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -102% -74% -265% 01 Jul 2025 30 Sep 2025
Q2 2025 -84% -53% -173% 01 Apr 2025 30 Jun 2025
Q1 2025 -74% -42% -136% 01 Jan 2025 31 Mar 2025
Q4 2024 -67% -25% -60% 01 Oct 2024 31 Dec 2024
Q3 2024 -28% +51% +64% 01 Jul 2024 30 Sep 2024
Q2 2024 -31% +56% +65% 01 Apr 2024 30 Jun 2024
Q1 2024 -31% +63% +67% 01 Jan 2024 31 Mar 2024
Q4 2023 -42% +47% +53% 01 Oct 2023 31 Dec 2023
Q3 2023 -78% +0.57% +0.72% 01 Jul 2023 30 Sep 2023
Q2 2023 -87% -19% -29% 01 Apr 2023 30 Jun 2023
Q1 2023 -95% -40% -75% 01 Jan 2023 31 Mar 2023
Q4 2022 -89% -43% -94% 01 Oct 2022 31 Dec 2022
Q3 2022 -79% -30% -60% 01 Jul 2022 30 Sep 2022
Q2 2022 -68% -12% -22% 01 Apr 2022 30 Jun 2022
Q1 2022 -54% +12% +18% 01 Jan 2022 31 Mar 2022
Q4 2021 -46% +53% +54% 01 Oct 2021 31 Dec 2021
Q3 2021 -50% +49% +50% 01 Jul 2021 30 Sep 2021
Q2 2021 -55% +42% +43% 01 Apr 2021 30 Jun 2021
Q1 2021 -66% +30% +31% 01 Jan 2021 31 Mar 2021
Q4 2020 -99% -3.7% -3.8% 01 Oct 2020 31 Dec 2020
Q3 2020 -98% -6.3% -6.9% 01 Jul 2020 30 Sep 2020
Q2 2020 -98% -9.6% -11% 01 Apr 2020 30 Jun 2020
Q1 2020 -96% -2.1% -2.3% 01 Jan 2020 31 Mar 2020
Q4 2019 -96% -15% -19% 01 Oct 2019 31 Dec 2019
Q3 2019 -92% -22% -31% 01 Jul 2019 30 Sep 2019
Q2 2019 -88% -28% -46% 01 Apr 2019 30 Jun 2019
Q1 2019 -93% -34% -57% 01 Jan 2019 31 Mar 2019
Q4 2018 -80% 01 Oct 2018 31 Dec 2018
Q3 2018 -70% 01 Jul 2018 30 Sep 2018
Q2 2018 -60% 01 Apr 2018 30 Jun 2018
Q1 2018 -59% 01 Jan 2018 31 Mar 2018

Rein Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2024 -67% -25% -60% 01 Jan 2024 31 Dec 2024
2023 -42% +47% +53% 01 Jan 2023 31 Dec 2023
2022 -89% -43% -94% 01 Jan 2022 31 Dec 2022
2021 -46% +83% +64% 01 Jan 2021 31 Dec 2021
2020 -128% -33% -35% 01 Jan 2020 31 Dec 2020
2019 -96% -15% -19% 01 Jan 2019 31 Dec 2019
2018 -80% 01 Jan 2018 31 Dec 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.